Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Cancer Colorectal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00276861
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer

Who this might be right for
Colorectal Cancer
University of Miami 10
Testing effectiveness (Phase 2)Temporarily pausedNCT05200442
What this trial is testing

VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColorectal Cancer Metastatic+2 more
University of Chicago 53
Large-scale testing (Phase 3)Study completedNCT00389870
What this trial is testing

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

Who this might be right for
Colorectal Cancer
University of Leeds 1,198
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Testing effectiveness (Phase 2)Study completedNCT01386242
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 108
Testing effectiveness (Phase 2)Study completedNCT00752570
What this trial is testing

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Who this might be right for
CancerCarcinomaColon Cancer+7 more
Amgen 144
Testing effectiveness (Phase 2)Study completedNCT02028442
What this trial is testing

Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

Who this might be right for
Solid Tumours of Epithelial OriginMetastatic Colorectal CancerMetastatic Bladder Cancer
Akamis Bio 61
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Testing effectiveness (Phase 2)Looking for participantsNCT06563986
What this trial is testing

FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
UMC Utrecht 40
Testing effectiveness (Phase 2)UnknownNCT02075086
What this trial is testing

Angiogenic Switch in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Grupo Hospital de Madrid 100
Testing effectiveness (Phase 2)Ended earlyNCT00251186
What this trial is testing

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Who this might be right for
Colorectal Cancer
University of Medicine and Dentistry of New Jersey 18
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Testing effectiveness (Phase 2)Study completedNCT00048139
What this trial is testing

Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 52
Post-approval studies (Phase 4)UnknownNCT06269445
What this trial is testing

The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sir Run Run Shaw Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT01767857
What this trial is testing

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Janssen Research & Development, LLC 643
Large-scale testing (Phase 3)Active Not RecruitingNCT03428477
What this trial is testing

EPA for Metastasis Trial 2

Who this might be right for
Liver MetastasisColon Cancer
Mark A Hull, PhD FRCP 418
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Large-scale testing (Phase 3)Study completedNCT02162563
What this trial is testing

Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Dutch Colorectal Cancer Group 530
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Next Page